Hepatitis B Foundation Commends New Rx Outreach Program to Provide Access to Affordable Hepatitis B Medication
DOYLESTOWN, PA (June 25, 2019): The Hepatitis B Foundation commends Rx Outreach, a nonprofit online pharmacy, for expanding their service to provide medications to help more than 2 million Americans who are chronically infected with hepatitis B. Through Rx Outreach’s online pharmacy, people will now have access to tenofovir disoproxil fumarate (TDF) and entecavir, two front-line medications used to treat hepatitis B, at prices significantly lower than retail. The Hepatitis B Foundation is proud to partner with Rx Outreach’s nonprofit pharmacy to identify the most commonly prescribed hepatitis B medications, and refer patients struggling with medication costs. The two nonprofits have partnered to improve health outcomes for people with hepatitis B, under the shared belief that everyone deserves access to affordable health services.
“Rx Outreach is proud to work with the Hepatitis B Foundation,” said Darryl Munden, President of Rx Outreach. “We know that countless chronically ill people in the United States have to choose between food and medication. This partnership aligns with our core strategies and belief that everyone deserves access to affordable medications."
Known for their exceptional attention to improving the quality of life for those affected by hepatitis B worldwide through education and patient advocacy as well as their focus on finding a cure through research, the Hepatitis B Foundation is a global leader in the field. They are recognized for making great strides for this mostly overlooked and underfunded disease.
“The Hepatitis B Foundation is pleased to direct people to a low-cost resource for two of the most commonly prescribed medications for chronic hepatitis B,” said Chari Cohen, DrPH, MPH, Senior Vice President of the Hepatitis B Foundation. “Nearly 20% of our phone calls in the first three months of this year were directly related to the rising cost of medicines. By partnering with Rx Outreach, Hepatitis B Foundation is improving access to life-saving treatment for people living with hepatitis B – and helping all stakeholders - family, friends, healthcare providers, community stakeholders, faith-based communities, and national organizations -- to create informative change within the field.”
Tenofovir disoproxil fumarate (TDF), generic Viread ®, retails for $838.85 for a 30-day supply but is available from Rx Outreach for $25 for up to 30 tablets. Entecavir, generic Baraclude ®, has an average monthly retail price of $981.66, but is available from Rx Outreach for $45 for up to 30 tablets. Individuals who meet the eligibility requirements will qualify for Rx Outreach’s affordable pricing regardless of their health insurance status or prescription coverage.
To learn more about this partnership, visit www.hepb.org/blog
To order medications from Rx Outreach, visit www.rxoutreach.org/hepb
The Hepatitis B Foundation does not financially benefit from this partnership.
About Rx Outreach
Rx Outreach is the nation's largest, nonprofit, fully licensed, mail order pharmacy and Patient Assistance Program (PAP). It offers more than 1,000 medication strengths at affordable prices. Missioned to provide affordable medication to the underserved, Rx Outreach partners with hundreds of clinics and organizations across the U.S. to provide a crucial health safety net for those who battle both illness and poverty. Since 2010, Rx Outreach has saved people in need more than $662 million on their prescription medications compared to retail costs. To learn more, go to www.rxoutreach.org/hepb. Follow Rx Outreach on Twitter https://twitter.com/RxOutreach, on Facebook https://www.facebook.com/RxOutreach and on LinkedIn https://www.linkedin.com/company/rx-outreach/
About The Hepatitis B Foundation
The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by Hepatitis B worldwide. Their commitment includes funding focused research, promoting disease awareness, supporting immunization and treatment initiatives, and serving as the primary source of information for patients and their families, the medical and scientific community, and the general public. To learn more, go to www.hepb.org, read our blog at www.hepb.org/blog, follow us on Twitter @HepBFoundation, find us on Facebook at http://www.facebook.com/hepbfoundation or call 215-489-4900.